BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 36071169)

  • 1. ILC3s select microbiota-specific regulatory T cells to establish tolerance in the gut.
    Lyu M; Suzuki H; Kang L; Gaspal F; Zhou W; Goc J; Zhou L; Zhou J; Zhang W; ; Shen Z; Fox JG; Sockolow RE; Laufer TM; Fan Y; Eberl G; Withers DR; Sonnenberg GF
    Nature; 2022 Oct; 610(7933):744-751. PubMed ID: 36071169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZBTB46 defines and regulates ILC3s that protect the intestine.
    Zhou W; Zhou L; Zhou J; ; Chu C; Zhang C; Sockolow RE; Eberl G; Sonnenberg GF
    Nature; 2022 Sep; 609(7925):159-165. PubMed ID: 35831503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A RORγt
    Kedmi R; Najar TA; Mesa KR; Grayson A; Kroehling L; Hao Y; Hao S; Pokrovskii M; Xu M; Talbot J; Wang J; Germino J; Lareau CA; Satpathy AT; Anderson MS; Laufer TM; Aifantis I; Bartleson JM; Allen PM; Paidassi H; Gardner JM; Stoeckius M; Littman DR
    Nature; 2022 Oct; 610(7933):737-743. PubMed ID: 36071167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-MAF-dependent regulatory T cells mediate immunological tolerance to a gut pathobiont.
    Xu M; Pokrovskii M; Ding Y; Yi R; Au C; Harrison OJ; Galan C; Belkaid Y; Bonneau R; Littman DR
    Nature; 2018 Feb; 554(7692):373-377. PubMed ID: 29414937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel antigen-presenting cell imparts T
    Akagbosu B; Tayyebi Z; Shibu G; Paucar Iza YA; Deep D; Parisotto YF; Fisher L; Pasolli HA; Thevin V; Elmentaite R; Knott M; Hemmers S; Jahn L; Friedrich C; Verter J; Wang ZM; van den Brink M; Gasteiger G; Grünewald TGP; Marie JC; Leslie C; Rudensky AY; Brown CC
    Nature; 2022 Oct; 610(7933):752-760. PubMed ID: 36070798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Liver X receptor regulates Th17 and RORγt
    Parigi SM; Das S; Frede A; Cardoso RF; Tripathi KP; Doñas C; Hu YOO; Antonson P; Engstrand L; Gustafsson JÅ; Villablanca EJ
    Mucosal Immunol; 2021 Mar; 14(2):411-419. PubMed ID: 32681027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis.
    Mortha A; Chudnovskiy A; Hashimoto D; Bogunovic M; Spencer SP; Belkaid Y; Merad M
    Science; 2014 Mar; 343(6178):1249288. PubMed ID: 24625929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ILC3s control airway inflammation by limiting T cell responses to allergens and microbes.
    Teng F; Tachó-Piñot R; Sung B; Farber DL; Worgall S; Hammad H; Lambrecht BN; Hepworth MR; Sonnenberg GF
    Cell Rep; 2021 Nov; 37(8):110051. PubMed ID: 34818549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RORγt Promotes Foxp3 Expression by Antagonizing the Effector Program in Colonic Regulatory T Cells.
    Bhaumik S; Mickael ME; Moran M; Spell M; Basu R
    J Immunol; 2021 Oct; 207(8):2027-2038. PubMed ID: 34518282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MUCOSAL IMMUNOLOGY. The microbiota regulates type 2 immunity through RORγt⁺ T cells.
    Ohnmacht C; Park JH; Cording S; Wing JB; Atarashi K; Obata Y; Gaboriau-Routhiau V; Marques R; Dulauroy S; Fedoseeva M; Busslinger M; Cerf-Bensussan N; Boneca IG; Voehringer D; Hase K; Honda K; Sakaguchi S; Eberl G
    Science; 2015 Aug; 349(6251):989-93. PubMed ID: 26160380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aryl hydrocarbon receptor promotes RORγt⁺ group 3 ILCs and controls intestinal immunity and inflammation.
    Qiu J; Zhou L
    Semin Immunopathol; 2013 Nov; 35(6):657-70. PubMed ID: 23975386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.
    Zhou L; Chu C; Teng F; Bessman NJ; Goc J; Santosa EK; Putzel GG; Kabata H; Kelsen JR; Baldassano RN; Shah MA; Sockolow RE; Vivier E; Eberl G; Smith KA; Sonnenberg GF
    Nature; 2019 Apr; 568(7752):405-409. PubMed ID: 30944470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aire-expressing ILC3-like cells in the lymph node display potent APC features.
    Yamano T; Dobeš J; Vobořil M; Steinert M; Brabec T; Ziętara N; Dobešová M; Ohnmacht C; Laan M; Peterson P; Benes V; Sedláček R; Hanayama R; Kolář M; Klein L; Filipp D
    J Exp Med; 2019 May; 216(5):1027-1037. PubMed ID: 30918005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defined microbiota transplant restores Th17/RORγt
    Britton GJ; Contijoch EJ; Spindler MP; Aggarwala V; Dogan B; Bongers G; San Mateo L; Baltus A; Das A; Gevers D; Borody TJ; Kaakoush NO; Kamm MA; Mitchell H; Paramsothy S; Clemente JC; Colombel JF; Simpson KW; Dubinsky MC; Grinspan A; Faith JJ
    Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21536-21545. PubMed ID: 32817490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The role of microbiota and flavonoids in maintaining the balance of helper and regulatory T-lymphocytes associated with the intestinal immune barrier].
    Pavlova SI
    Vopr Pitan; 2024; 93(1):22-32. PubMed ID: 38555607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A T-bet gradient controls the fate and function of CCR6-RORγt+ innate lymphoid cells.
    Klose CS; Kiss EA; Schwierzeck V; Ebert K; Hoyler T; d'Hargues Y; Göppert N; Croxford AL; Waisman A; Tanriver Y; Diefenbach A
    Nature; 2013 Feb; 494(7436):261-5. PubMed ID: 23334414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bcl6 is a subset-defining transcription factor of lymphoid tissue inducer-like ILC3.
    Tachó-Piñot R; Stamper CT; King JI; Matei-Rascu V; Richardson E; Li Z; Roberts LB; Bassett JW; Melo-Gonzalez F; Fiancette R; Lin IH; Dent A; Harada Y; Finlay C; Mjösberg J; Withers DR; Hepworth MR
    Cell Rep; 2023 Nov; 42(11):113425. PubMed ID: 37950867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human RORγt(+)CD34(+) cells are lineage-specified progenitors of group 3 RORγt(+) innate lymphoid cells.
    Montaldo E; Teixeira-Alves LG; Glatzer T; Durek P; Stervbo U; Hamann W; Babic M; Paclik D; Stölzel K; Gröne J; Lozza L; Juelke K; Matzmohr N; Loiacono F; Petronelli F; Huntington ND; Moretta L; Mingari MC; Romagnani C
    Immunity; 2014 Dec; 41(6):988-1000. PubMed ID: 25500367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysregulation of ILC3s unleashes progression and immunotherapy resistance in colon cancer.
    Goc J; Lv M; Bessman NJ; Flamar AL; Sahota S; Suzuki H; Teng F; Putzel GG; ; Eberl G; Withers DR; Arthur JC; Shah MA; Sonnenberg GF
    Cell; 2021 Sep; 184(19):5015-5030.e16. PubMed ID: 34407392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial transcription factor A in RORγt
    Fu Z; Dean JW; Xiong L; Dougherty MW; Oliff KN; Chen ZE; Jobin C; Garrett TJ; Zhou L
    Nat Commun; 2021 Jul; 12(1):4462. PubMed ID: 34294718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.